Prof. Dr. Michael Sticherling



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Differential expression of toll like receptors and antibiotic peptides by human keratinocytes (2019) Heusinger J, Herter-Kermann T, Sticherling M Conference contribution S2k guidelines for the treatment of psoriasis in children and adolescents – Short version part 1 (2019) Eisert L, Augustin M, Bach S, Dittmann M, Eiler R, Fölster-Holst R, Gerdes S, et al. Journal article S2k-Leitlinie zur Therapie der Psoriasis bei Kindern und Jugendlichen – Kurzfassung Teil 1 (2019) Eisert L, Augustin M, Bach S, Dittmann M, Eiler R, Fölster-Holst R, Gerdes S, et al. Journal article PU.1 controls fibroblast polarization and tissue fibrosis (2019) Wohlfahrt T, Rauber S, Uebe S, Luber M, Soare A, Ekici AB, Weber S, et al. Journal article A matter of perspective: Imputation methods and their effects illustrated with the use of data from the PRIME study (2018) Reich K, Bachhuber T, Melzer N, Sieder C, Sticherling M Conference contribution DISEASE INTERCEPTION IN PSORIASIS PATIENTS WITH SUBCLINICAL JOINT INFLAMMATION BY INTERLEUKIN 17 INHIBITION WITH SECUKINUMAB - DATA FROM A PROSPECTIVE OPEN LABEL STUDY (2018) Kamoylafka E, Oliveira ID, Linz C, Lerchen V, Englbrecht M, Simon D, Sticherling M, et al. Conference contribution Systemic therapy with calcitonin has positive clinical effects on systemic sclerosis in patients with cutaneous manifestations (2018) Uslu U, Streiff L, Sticherling M Journal article Prospective study in bullous pemphigoid: association of high serum anti-BP180 IgG levels with increased mortality and reduced Karnofsky score (2018) Holtsche MM, Goletz S, Van Beek N, Zillikens D, Benoit S, Harman K, Walton S, et al. Journal article From relative to absolute treatment outcomes-Correlation of PASI 90 and PASI <= 2 in three clinical trials with secukinumab (2018) Reich K, Bachhuber T, Melzer N, Sieder C, Sticherling M Conference contribution From relative to absolute Treatment Goals - Correlation of PASI 90 and PASI <=2 in three clinical Studies with Secukinumab (2018) Reich K, Bachhuber T, Melzer N, Sieder C, Sticherling M Conference contribution